Legal Representation
Attorney
Christopher D. Olszyk, Jr.
USPTO Deadlines
Next Deadline
962 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-03-22)
Due Date
March 22, 2028
Grace Period Ends
September 22, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
44 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 22, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 18, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Feb 17, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Feb 9, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 8, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 8, 2022 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Feb 8, 2022 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Jan 28, 2022 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Jan 28, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 28, 2022 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jan 28, 2022 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Jan 28, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jan 28, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 29, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 27, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 27, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 27, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 10, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 10, 2021 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Mar 9, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 9, 2021 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Feb 16, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jan 28, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 28, 2021 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Jan 28, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 7, 2020 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Jul 28, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 17, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 17, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 17, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 2, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 2, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 13, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 28, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 21, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 20, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 20, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 20, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 3, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 3, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 3, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 29, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 14, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 9, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 010
Biopsy tests and devices, namely, medical instruments for use in performing tissue biopsies and medical diagnostic apparatus for testing biomarkers; cancer screening tests and devices, namely, medical devices for detecting risk factors and probability of cancer reoccurrence; medical testing device for diagnosing cancer and detecting bioloigical traits that effect the risk of reoccurrence; medical testing devices for tumor diagnosis
First Use Anywhere:
20200200
First Use in Commerce:
20200200
Classification
International Classes
010